Due to the important role of SIRT4 and SIRT5 in metabolic regulation, they have the potential to become a new direction in the treatment of metabolic diseases and tumors, and the development of related agonists or inhibitors will also become a hot field. This evidence concerns the gene SIRT5 and metabolic disease.